Liberate Ideas Joins Healthcare and Life Sciences Leaders in Advancing Patient Centricity
Richard Nordstrom, CEO, Liberate Ideas Inc., joined other healthcare and life science leaders - including Ernst & Young, Sanofi, Pfizer and patient advocacy organizations - to discuss ways to move the health care industry forward "from patient adherence to patient centricity." Insights from this 2015 EY New Jersey Life Science and Healthcare Summit, held earlier this summer were just released.
Montclair, New Jersey, September 29, 2015 (Newswire.com) - “Among our insights to succeed in delivering a patient-centered healthcare ecosystem,” said Nordstrom, “is the importance of placing the patient at the forefront, and communicating with them in ways that resonate. At the core of patient engagement is communications, yet we are not advancing effective health communications when patients typically understand just 10% of what they are being told by their provider.” Nordstrom added, “As an industry, this huge deficiency in effective health communications is among our greatest challenges."
In her keynote speech, Dr. Kalahn Taylor-Clark, PhD, MPH, Sanofi Associate VP and Global Head, Patient Engagement Strategy, spoke about how “RTP, Return To Patient” must become the new healthcare business model. “It’s not about building your brand by focusing on ROI, it’s about understanding the RTP -- things that matter most to patients,” she said.
Only when all patients gain the ability to become empowered partners in their own health outcomes will we see significant care improvements among many health conditions. Innovative, patient-centric communications processes and tools are key to achieving success."
Richard Nordstrom, CEO, Liberate Ideas Inc
A critical care component to improving patient satisfaction is delivering better collaborative communications models for patients, healthcare providers and their pharma partners. This includes providing proof via test metrics that matter in this new RTP world, said Nordstrom. In recent clinical experience trials at Abington Memorial Hospital, Liberate Health’s digital medical-conditions education application proved worthy among physicians and patients. Ninety percent (90%) of physicians believed that Liberate Health’s software improved their patients’ understanding of their condition and was easy to use. Liberate Health’s next clinical trial scheduled to begin in late 2015 is powered to measure economic impacts, including improving patient satisfaction scores, 30-readmittance, and ER room visit.
About Liberate Ideas, Inc.
Liberate Ideas, Inc., is a Delaware-based corporation driven by the mission to improve health outcomes. By creating a host of free, mobile and web-based, point-of-care patient education platforms that are continually updated, Liberate Health delivers digital tools into the hands of clinicians and their patients, and harnesses actionable, real-time data to drive insights. http://liberatehealth.us/
For more information: Media contact:
Ray Roel
Liberate Ideas Corporate Communications- ray.roel@live.com
P: 631-754-2986
Liberate Health: http://liberatehealth.us/